Company · CIK 1583107
Theravance Biopharma, Inc.
| CIK | 1583107 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | CA |
| Business address | CA |
| Listed | TBPH (Nasdaq) |
| First annual or quarterly report | 2014-06-24 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-235339 | 2019-12-03 | 2021-06-25 | 5 | |
| 333-248534 | 2020-09-01 | 2020-09-01 | 1 | |
| 333-214257 | 2016-10-26 | 2016-10-31 | 5 | |
| 333-205275 | 2015-06-26 | 2016-04-29 | 5 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-06-25 | 424B5Shelf takedown | 333-235339 | 0001104659-21-085711 |
| 2021-06-24 | 424B5Shelf takedown | 333-235339 | 0001104659-21-085123 |
| 2020-09-01 | S-3ASRShelf registered | 333-248534 | 0001104659-20-101456 |
| 2020-02-12 | 424B5Shelf takedown | 333-235339 | 0001047469-20-000842 |
| 2020-02-10 | 424B5Shelf takedown | 333-235339 | 0001047469-20-000779 |
| 2019-12-03 | S-3ASRShelf registered | 333-235339 | 0001047469-19-006605 |
| 2016-10-31 | 424B5Shelf takedown | 333-214257 | 0001047469-16-016388 |
| 2016-10-31 | 424B5Shelf takedown | 333-214257 | 0001047469-16-016386 |
| 2016-10-26 | 424B5Shelf takedown | 333-214257 | 0001047469-16-016313 |
| 2016-10-26 | 424B5Shelf takedown | 333-214257 | 0001047469-16-016312 |
| 2016-10-26 | S-3ASRShelf registered | 333-214257 | 0001047469-16-016307 |
| 2016-04-29 | 424B5Shelf takedown | 333-205275 | 0001047469-16-012708 |
| 2016-04-27 | 424B5Shelf takedown | 333-205275 | 0001047469-16-012613 |
| 2015-10-26 | 424B5Shelf takedown | 333-205275 | 0001047469-15-008037 |
| 2015-07-16 | EFFECTDeclared effective | 333-205275 | 9999999995-15-001956 |
| 2015-06-26 | S-3Shelf registered | 333-205275 | 0001047469-15-005813 |